Clinical Report: What Happens When You Read DNA and RNA Together?

Overview

Researchers have developed a single-cell multiomic sequencing platform, SDR-seq, enabling simultaneous analysis of genomic DNA and RNA in thousands of individual cells. This method provides insights into how genetic variants influence gene expression, particularly in cancer and stem cell research.

Background

The ability to link genotype to phenotype at the single-cell level is crucial for understanding disease mechanisms and developing targeted therapies. Traditional methods often fall short in correlating genetic variants with their transcriptional effects. SDR-seq addresses this gap by integrating genomic and transcriptomic data, which is essential for advancing personalized medicine.

Data Highlights

No numerical data available in the article.

Key Findings

• SDR-seq can profile up to 480 genomic loci and gene expression profiles per cell.
• The method identified distinct gene expression patterns influenced by both coding and noncoding variants in human iPSCs.
• In B cell lymphoma samples, SDR-seq revealed a correlation between mutational burden and gene expression signatures related to tumor behavior.
• Cells with higher mutation counts showed increased B cell receptor signaling and elevated tumorigenesis-related gene expression.
• SDR-seq may facilitate functional phenotyping by linking variant profiles to gene expression outcomes in disease-relevant cell types.

Clinical Implications

SDR-seq represents a promising tool for clinical laboratories and translational researchers, potentially enhancing the understanding of variant combinations that drive disease mechanisms. Its application could lead to improved diagnostic strategies for variants of uncertain significance, particularly in oncology.

Conclusion

The development of SDR-seq marks a significant advancement in single-cell analysis, providing a scalable framework for understanding the regulatory networks underlying various pathologies. This method holds potential for future applications in personalized medicine and cancer treatment.

Related Resources & Content

1. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025 - PubMed
2. Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial | Nature Medicine
3. Emerging clinical applications of single-cell RNA sequencing in oncology | Nature Reviews Clinical Oncology
4. the pathologist — Unlocking Hidden RNA Signals
5. the medicine maker — What I Learned Bringing Slalom Chromatography Back from the Dead
6. the analytical scientist — Turning Proteins into DNA for Ultra-Sensitive Sequencing
7. the analytical scientist — GlycoRNA Comes into Focus with Mass Spectrometry Blueprint
8. Unlocking Hidden RNA Signals
9. What I Learned Bringing Slalom Chromatography Back from the Dead
10. Turning Proteins into DNA for Ultra-Sensitive Sequencing
11. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025 - PubMed
12. Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial | Nature Medicine
13. Emerging clinical applications of single-cell RNA sequencing in oncology | Nature Reviews Clinical Oncology